Recent Advances in Single-Cell Analysis of Atherosclerotic Plaque Biology

JMA J. 2026 Jan 15;9(1):24-37. doi: 10.31662/jmaj.2025-0397. Epub 2025 Dec 12.ABSTRACTAtherosclerosis, the leading cause of coronary artery disease, stroke, and peripheral arterial disease, is now recognized as a lipid-driven disease complicated by an immune response that plays a major role in its p

Y Yusuke Adachi

2025: The year in cardiovascular disease - the year of triglyceride lowering therapies. Can we effectively reduce triglyceride-related residual cardiovascular disease and pancreatitis risk?

Arch Med Sci. 2025 Dec 31;21(6):2229-2245. doi: 10.5114/aoms/216960. eCollection 2025.ABSTRACTThis state-of-the-art review surveys the rapidly advancing field of triglyceride-lowering therapies as of 2025, positioning hypertriglyceridemia (HTG) as both a residual driver of atherosclerotic cardiovasc

P Peter P Toth

Revascularisation in Patients with Cancer: A Review

Eur Cardiol. 2026 Jan 21;21:e02. doi: 10.15420/ecr.2025.14. eCollection 2026.ABSTRACTThe emerging field of cardio-oncology has grown considerably over the past two decades. While the issue of myocardial cardiotoxicity has received the most attention, it is now recognised that cardio-oncology encompa

M Miguel Nobre Menezes

The role of CD36 in immune function: bridging innate and adaptive responses

Front Immunol. 2026 Jan 27;17:1728509. doi: 10.3389/fimmu.2026.1728509. eCollection 2026.ABSTRACTCD36 is a multifunctional glycoprotein essential in fatty acid metabolism, angiogenesis, and atherogenesis, playing a critical role in immunological processes. This comprehensive review synthesizes curre

X Xiang Zhang